Jonathan Bush and Chris Severn discuss how regulatory changes impacted their companies' innovations, emphasizing the importance of collaborating with policymakers. They delve into navigating price transparency regulations and creating a competitive advantage in healthcare. The episode also explores evolving strategies in the market, the CEO's role in compliance, and potential future disruptions in the healthcare industry.